Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073

Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073

“…We greatly appreciate the letter from Rios et al (1) in which they report a lack of association between basal or glucagon-stimulated C-peptide and basophil counts in recently diagnosed type 1 diabetic patients followed for 1 year. This is precisely the type of analysis of other datasets that we hoped to stimulate with our article (2).…”